• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Strategies for developing self-assembled nanoparticle vaccines against SARS-CoV-2 infection

tetano

Editor, Senior Moderator
Front Immunol


. 2024 Sep 11:15:1392898.
doi: 10.3389/fimmu.2024.1392898. eCollection 2024. Strategies for developing self-assembled nanoparticle vaccines against SARS-CoV-2 infection

Kaiwen Yang[SUP] 1 2 [/SUP], Youqin Zeng[SUP] 1 2 [/SUP], Xinyu Wu[SUP] 1 2 [/SUP], Jia Li[SUP] 1 2 [/SUP], Jinlin Guo[SUP] 1 2 [/SUP]



Affiliations
Abstract

In the recent history of the SARS-CoV-2 outbreak, vaccines have been a crucial public health tool, playing a significant role in effectively preventing infections. However, improving the efficacy while minimizing side effects remains a major challenge. In recent years, there has been growing interest in nanoparticle-based delivery systems aimed at improving antigen delivery efficiency and immunogenicity. Among these, self-assembled nanoparticles with varying sizes, shapes, and surface properties have garnered considerable attention. This paper reviews the latest advancements in the design and development of SARS-CoV-2 vaccines utilizing self-assembled materials, highlighting their advantages in delivering viral immunogens. In addition, we briefly discuss strategies for designing a broad-spectrum universal vaccine, which provides insights and ideas for dealing with possible future infectious sarbecoviruses.

Keywords: SARS-CoV-2; VLP; ferritin; self-assembled nanoparticle; vaccine.

 
Back
Top Bottom